<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03217006</url>
  </required_header>
  <id_info>
    <org_study_id>1703018094</org_study_id>
    <nct_id>NCT03217006</nct_id>
  </id_info>
  <brief_title>Randomization of Single vs Multiple Arterial Grafts</brief_title>
  <acronym>ROMA</acronym>
  <official_title>Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heartcenter Leipzig GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rotterdam, The Netherlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College Hospital Galway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ottawa Heart Institute Research Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Toledo Health Science Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent
      coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a
      single arterial graft is associated with a reduction in the composite outcome of death from
      any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization.
      The secondary hypothesis is that in patients undergoing primary isolated non-emergent CABG,
      the use of two or more arterial grafts compared to a single arterial graft is associated with
      improved survival.

      Prospective event-driven unblinded randomized multicenter trial of at least 4,300 subjects
      enrolled in at least 25 international centers. Patients will be randomized to a single
      arterial graft (SAG) or multiple arterial grafts (MAG). Patients will be randomized in a 1:1
      fashion between the two groups. Permuted block randomization with random blocks stratified by
      the center and the type of second arterial graft will be used to provide treatment
      distribution in equal proportion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the 1980's, it was recognized that long-term survival was enhanced in patients undergoing
      coronary surgery when the left anterior descending (LAD) was grafted with a left internal
      thoracic artery (ITA) rather than a saphenous vein (1). This difference was predicated, at
      least in part, due to greater and more durable patency of the left ITA compared to an
      increased early occlusion rate and later progressive atherosclerosis of saphenous vein grafts
      (SVG) (2).

      For more than 20 years it has generally been accepted that patients who receive multiple
      arterial grafts (AGs) at the time of coronary artery bypass surgery (CABG) have increased
      postoperative survival compared to those who receive only one AG, especially over the long
      term (3-5). The current United States and European Guidelines encourage the use of AGs in
      patients with a long life expectancy (6, 7). Last year, a position paper from the Society of
      Thoracic Surgeons strongly recommended a wider use of AGs (8).

      The putative mechanism underlying the AG hypothesis is greater patency. In line with the
      original findings of improved LAD graft patency with ITA vs. SVG, data from randomized
      control trials (RCTs) as well as observational studies and a network meta-analysis (9) have
      demonstrated that the patency of the RA, as well as the right ITA, exceed that of a SVG,
      providing mechanistic basis to support the AG hypothesis.

      ROMA is a two arm event driven randomized multi-centre trial aimed at evaluating the impact
      of the use of one ITA vs two or more AGs for CABG on a composite of death from any cause, any
      stroke, post discharge myocardial infarction and/or repeat revascularization. The trial is
      powered to detect a 20% relative reduction in the primary outcome with 90% power at 5% alpha.

      The primary aim is to conduct a multicenter international randomized control trial to test
      the hypothesis that the use of a two or more AGs compared to a single arterial graft is
      associated with a reduction in the composite outcome of death from any cause, any stroke,
      post discharge myocardial infarction and/or repeat revascularization.

      The secondary aim is to conduct a multicenter international randomized control trial to test
      the hypothesis that the use of two or more AGs compared to a single arterial graft is
      associated with improved survival.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients undergoing coronary artery bypass surgery will be in one of two groups. One group will receive a single arterial graft and the second group will receive two or more arterial grafts.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The endpoint assessors will be blinded to treatment allocation (PROBE).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Outcome</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years</time_frame>
    <description>A composite of death from any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary Secondary Outcome (Overall mortality)</measure>
    <time_frame>Analysis will be performed after 631 events. The investigators assume this will occur at a mean follow-up of 10 years</time_frame>
    <description>All cause mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major postoperative complications</measure>
    <time_frame>In-hospital stay, up to 30 days post-operatively</time_frame>
    <description>Revision for bleeding, perioperative myocardial infarction, any stroke, need for dialysis, need for tracheostomy, and surgical site infection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Outcome</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years</time_frame>
    <description>A composite of death from any cause, post discharge myocardial infarction, and/or repeat revascularization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Outcome</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years.</time_frame>
    <description>A composite of death from any cause, any stroke, any myocardial infarction, and/or repeat revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years.</time_frame>
    <description>Any stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative myocardial infarct</measure>
    <time_frame>Up to 30 days post-operatively</time_frame>
    <description>Any post-operative myocardial infarct</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat revascularization</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years.</time_frame>
    <description>Any post-operative repeat revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cause specific mortality</measure>
    <time_frame>Analysis will be performed after 845 events. The investigators assume this will occur at a mean follow-up of 5 years</time_frame>
    <description>Death as either cardiac or non-cardiac in etiology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death from any cause at 30-days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harvest site complications</measure>
    <time_frame>6 months</time_frame>
    <description>Any complication directly related to the harvest site</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">4300</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Heart Diseases</condition>
  <arm_group>
    <arm_group_label>Single Arterial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will receive a single arterial graft which will be the left internal thoracic artery. Additional grafts used in this group will all be venous grafts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple Arterial Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the group will receive multiple arterial grafts. All patients will receive at least two arterial grafts, the left internal thoracic artery with the addition of either the right internal thoracic artery or the radial artery as the second conduit. Some patients may receive additional arterial grafts consisting of the radial artery, the right internal thoracic artery, or the right gastroepiploic artery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single arterial graft</intervention_name>
    <description>This interventions consists of patients receiving the left internal thoracic artery to the left anterior descending coronary artery of the heart. In addition to the left internal thoracic artery patients will receive venous grafts for all additional grafting.</description>
    <arm_group_label>Single Arterial Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multiple arterial grafting</intervention_name>
    <description>This intervention consists of the patient receiving the left internal thoracic artery to the left anterior descending coronary artery of the heart. The second arterial graft (right internal thoracic artery or radial artery) will be directed to the major branch of the circumflex. Additional grafts will include saphenous veins or arterial conduits.</description>
    <arm_group_label>Multiple Arterial Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary isolated CABG patients with disease of the left main coronary artery and/or of
             the left anterior descending and the circumflex coronary system with or without
             disease of the right coronary artery.

        Exclusion Criteria:

          -  Age &gt; 70 years

          -  Single graft

          -  Emergency operation

          -  Evolving myocardial infarction within 48 hours of surgery

          -  Left ventricular ejection fraction of &lt; 35%

          -  Any concomitant cardiac or non-cardiac procedure

          -  Previous cardiac surgery

          -  Preoperative severe end-organ dysfunction (dialysis, liver failure, respiratory
             failure), cancer or any co-morbidity that reduce life expectancy to less than 5 years.

          -  Inability to use the saphenous vein or to use both radial and right internal thoracic
             arteries

          -  Anticipated need for coronary thrombo-endarterectomy

          -  Planned hybrid revascularization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario Gaudino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Cornell Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen Fremes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mario Gaudino, MD</last_name>
    <phone>212.746.1812</phone>
    <email>mfg9004@med.cornell.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Renee Aviv</last_name>
    <phone>(212) 746-5194</phone>
    <email>rek9015@med.cornell.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, Golding LA, Gill CC, Taylor PC, Sheldon WC, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986 Jan 2;314(1):1-6.</citation>
    <PMID>3484393</PMID>
  </reference>
  <reference>
    <citation>Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over 15 years. Ann Thorac Surg. 2004 Jan;77(1):93-101.</citation>
    <PMID>14726042</PMID>
  </reference>
  <reference>
    <citation>Lytle BW, Blackstone EH, Loop FD, Houghtaling PL, Arnold JH, Akhrass R, McCarthy PM, Cosgrove DM. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg. 1999 May;117(5):855-72.</citation>
    <PMID>10220677</PMID>
  </reference>
  <reference>
    <citation>Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet. 2001 Sep 15;358(9285):870-5.</citation>
    <PMID>11567701</PMID>
  </reference>
  <reference>
    <citation>Yi G, Shine B, Rehman SM, Altman DG, Taggart DP. Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach. Circulation. 2014 Aug 12;130(7):539-45. doi: 10.1161/CIRCULATIONAHA.113.004255. Epub 2014 Jun 10.</citation>
    <PMID>24916209</PMID>
  </reference>
  <reference>
    <citation>Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 6;124(23):e652-735. doi: 10.1161/CIR.0b013e31823c074e. Epub 2011 Nov 7. Erratum in: Circulation. 2011 Dec 20;124(25):e957.</citation>
    <PMID>22064599</PMID>
  </reference>
  <reference>
    <citation>Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.</citation>
    <PMID>25173339</PMID>
  </reference>
  <reference>
    <citation>Aldea GS, Bakaeen FG, Pal J, Fremes S, Head SJ, Sabik J, Rosengart T, Kappetein AP, Thourani VH, Firestone S, Mitchell JD; Society of Thoracic Surgeons. The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting. Ann Thorac Surg. 2016 Feb;101(2):801-9. doi: 10.1016/j.athoracsur.2015.09.100. Epub 2015 Dec 8.</citation>
    <PMID>26680310</PMID>
  </reference>
  <reference>
    <citation>Benedetto U, Raja SG, Albanese A, Amrani M, Biondi-Zoccai G, Frati G. Searching for the second best graft for coronary artery bypass surgery: a network meta-analysis of randomized controlled trials†. Eur J Cardiothorac Surg. 2015 Jan;47(1):59-65; discussion 65. doi: 10.1093/ejcts/ezu111. Epub 2014 Mar 30.</citation>
    <PMID>24686003</PMID>
  </reference>
  <reference>
    <citation>Nasso G, Coppola R, Bonifazi R, Piancone F, Bozzetti G, Speziale G. Arterial revascularization in primary coronary artery bypass grafting: Direct comparison of 4 strategies--results of the Stand-in-Y Mammary Study. J Thorac Cardiovasc Surg. 2009 May;137(5):1093-100. doi: 10.1016/j.jtcvs.2008.10.029. Epub 2009 Feb 7.</citation>
    <PMID>19379973</PMID>
  </reference>
  <reference>
    <citation>Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M; ART Investigators. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016 Dec 29;375(26):2540-9. doi: 10.1056/NEJMoa1610021. Epub 2016 Nov 14.</citation>
    <PMID>27959712</PMID>
  </reference>
  <reference>
    <citation>Zhang H, Wang ZW, Wu HB, Hu XP, Zhou Z, Xu P. Radial artery graft vs. saphenous vein graft for coronary artery bypass surgery : which conduit offers better efficacy? Herz. 2014 Jun;39(4):458-65. doi: 10.1007/s00059-013-3848-5. Epub 2013 Jun 21. Review.</citation>
    <PMID>23784362</PMID>
  </reference>
  <reference>
    <citation>Harskamp RE, Alexander JH, Ferguson TB Jr, Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial. Circulation. 2016 Jan 12;133(2):131-8. doi: 10.1161/CIRCULATIONAHA.115.015549. Epub 2015 Dec 8.</citation>
    <PMID>26647082</PMID>
  </reference>
  <reference>
    <citation>Lopes RD, Mehta RH, Hafley GE, Williams JB, Mack MJ, Peterson ED, Allen KB, Harrington RA, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB Jr, Alexander JH; Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012 Feb 14;125(6):749-56. doi: 10.1161/CIRCULATIONAHA.111.040311. Epub 2012 Jan 11.</citation>
    <PMID>22238227</PMID>
  </reference>
  <reference>
    <citation>Shavadia J, Norris CM, Graham MM, Verma S, Ali I, Bainey KR. Symptomatic graft failure and impact on clinical outcome after coronary artery bypass grafting surgery: Results from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry. Am Heart J. 2015 Jun;169(6):833-40. doi: 10.1016/j.ahj.2015.02.022. Epub 2015 Mar 13.</citation>
    <PMID>26027621</PMID>
  </reference>
  <reference>
    <citation>Gaudino M, Puskas JD, Di Franco A, Ohmes LB, Iannaccone M, Barbero U, Glineur D, Grau JB, Benedetto U, D'Ascenzo F, Gaita F, Girardi LN, Taggart DP. Three Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies. Circulation. 2017 Mar 14;135(11):1036-1044. doi: 10.1161/CIRCULATIONAHA.116.025453. Epub 2017 Jan 24. Review.</citation>
    <PMID>28119382</PMID>
  </reference>
  <reference>
    <citation>Yanagawa B, Verma S, Mazine A, Tam DY, Jüni P, Puskas JD, Murugavel S, Friedrich JO. Impact of total arterial revascularization on long term survival: A systematic review and meta-analysis of 130,305 patients. Int J Cardiol. 2017 Apr 15;233:29-36. doi: 10.1016/j.ijcard.2017.02.010. Epub 2017 Feb 5. Review.</citation>
    <PMID>28185702</PMID>
  </reference>
  <reference>
    <citation>Benedetto U, Gaudino M, Caputo M, Tranbaugh RF, Lau C, Di Franco A, Ng C, Girardi LN, Angelini GD. Right internal thoracic artery versus radial artery as the second best arterial conduit: Insights from a meta-analysis of propensity-matched data on long-term survival. J Thorac Cardiovasc Surg. 2016 Oct;152(4):1083-1091.e15. doi: 10.1016/j.jtcvs.2016.05.022. Epub 2016 May 28.</citation>
    <PMID>27342731</PMID>
  </reference>
  <reference>
    <citation>Hayward PA, Buxton BF. Mid-term results of the Radial Artery Patency and Clinical Outcomes randomized trial. Ann Cardiothorac Surg. 2013 Jul;2(4):458-66. doi: 10.3978/j.issn.2225-319X.2013.07.18.</citation>
    <PMID>23977623</PMID>
  </reference>
  <reference>
    <citation>Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G, Nasso G, Possati G. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation. 2005 Aug 30;112(9 Suppl):I265-9.</citation>
    <PMID>16159829</PMID>
  </reference>
  <reference>
    <citation>Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585-612.</citation>
    <PMID>795448</PMID>
  </reference>
  <reference>
    <citation>Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schönberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005 Aug 16;46(4):575-81.</citation>
    <PMID>16098418</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2017</study_first_submitted>
  <study_first_submitted_qc>July 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2017</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>coronary artery bypass surgery</keyword>
  <keyword>multiple arterial graft</keyword>
  <keyword>radial artery graft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

